Polydex Pharmaceuticals Limited announced earnings results for the first quarter ended April 30, 2018. For the quarter, the company reported sales of $1,480,305 against $1,260,085 a year ago. Net income was $104,948 against $149,159 a year ago. Basic and diluted income per share was $0.03 against $0.04 a year ago. Sales increased in the first quarter of fiscal 2019, but net income was impacted by influences outside company’s control, such as foreign exchange and market vagaries impacted by worldwide political and economic factors.